Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
M&G Advisors is a prominent global investment manager and a subsidiary of M&G plc, specializing in asset management across various sectors, including a significant focus on life sciences and healthcare. Through its specialized investment arms like M&G Catalyst, the firm provides scale-up capital to innovative biotech and healthcare companies addressing global challenges. The company manages a diverse portfolio that includes private equity, infrastructure, and sustainable investments, often targeting breakthrough medical technologies and therapeutic platforms. M&G Advisors plays a crucial role in the biotech ecosystem by providing the long-term funding necessary for clinical development and commercialization of novel therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on M&G Advisors.